Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 149   

Articles published

BMY 51.95 +1.39 (2.75%)
price chart
Weekly CFO Sells Highlight: Williams Companies Inc, Google Inc, Bristol-Myers ...
According to GuruFocus Insider Data, the recent CFO sales were: Williams Companies Inc, Google Inc, and Bristol-Myers Squibb Company. Williams Companies Inc. (WMB): Sr. Vice President & CFO Donald R Chappel sold 50,000 Shares. On 10/13/2014, ...
Analyst Upgrades: Baidu Inc (ADR), Bristol-Myers Squibb Co, and Tiffany & Co.
Analysts are weighing in today on Chinese Internet company Baidu Inc (ADR) (NASDAQ:BIDU), pharmaceutical firm Bristol-Myers Squibb Co (NYSE:BMY), and high-end jeweler Tiffany & Co. (NYSE:TIF). Here's a quick roundup of today's bullish brokerage ...
Bristol-Myers Squibb Upgraded to "Outperform" by BMO Capital ...  WKRB News
Chester firm expands operations  Cheshire Today
Related articles »  
Stocks to Watch: HomeAway, Inc. (NASDAQ:AWAY), Bristol-Myers Squibb Co ...
HomeAway, Inc. (NASDAQ:AWAY) received a buy investment rating from BMO Capital Markets, which initiated coverage Tuesday of the operator of an online marketplace for the vacation-rental industry with a price target of $42, recommending that clients ...
Related articles »  
Bristol-Myers Squibb announces creation of 200 jobs in Chester
Chester MP Stephen Mosley met with representatives from Bristol-Myers Squibb last week to discuss their plans for expanding current operations on Chester Business Park and in the UK.
Investor's Watch List � Citigroup Inc (NYSE:C), Bristol-Myers Squibb Co ...  Techsonian (press release)
Bristol-Myers Squibb Given AA- Credit Rating (BMY)  Ticker Report
Related articles »  
Morgan Stanley Believes Bristol-Myers Squibb Co. Could Move Significantly ...
In a report published Thursday, Morgan Stanley analyst David Risinger reiterated an Overweight rating and $60.00 price target on Bristol-Myers Squibb Co. (NYSE: BMY). In the report, Morgan Stanley noted, �We think BMY stock could move up 10�15% to ...
Bristol-Myers Squibb Presents Data from Multiple New Studies at IDWeek 2014 ...  Business Wire (press release)
Market Update: Bristol-Myers Squibb Company (NYSE:BMY) - Bristol-Myers ...  Jutia Group
Related articles »  
Gilead Sciences, Inc., Merck & Co., Inc., Bristol-Myers Squibb Co: Getting A ...
In addition, the first of a promising class of new cancer drugs from Bristol-Meyers Squibb Co.(NYSE: BMY) and Tokyo-based Ono Pharmaceuticals Co. hit the market in Japan in early September at an average annual cost per patient of $143,000.
Gilead Sciences, Inc. Takes Aim at Bristol-Myers Squibb  Motley Fool
Warning to Gilead, AbbVie and BMS: France has a new tax for pricey hep C meds  FiercePharma
Related articles »  
Stock Update: Bristol-Myers Squibb Company (NYSE:BMY) - Bristol-Myers ...
Bristol-Myers Squibb Company (NYSE:BMY) [Business Wire] - Bristol-Myers Squibb Company , Pharmacyclics, Inc. , and Janssen Research & Development, LLC announced today they have entered into a clinical trial collaboration agreement to evaluate the ...
Bristol-Myers Squibb, Pharmacyclics and Janssen Announce Clinical ...  Pharmaceutical Processing
Bristol-Myers Squibb Company : Bristol-Myers Squibb, Pharmacyclics and ...  The Wall Street Transcript
Related articles »  
Better Dividend Stock: Merck & Co. Inc. or Bristol-Myers Squibb Co.?
Dividend stocks are arguably the most critical component to the success of any long-term investor. According to the latest statistics from FactSet, S&P 500 companies paid out a whopping $91.5 billion in dividends during the second quarter, or an ...
Related articles »  
Why Bristol-Myers Squibb (BMY) Stock Declined Today
This is a clear sign of strength within the company. Compared to other companies in the Pharmaceuticals industry and the overall market on the basis of return on equity, BRISTOL-MYERS SQUIBB CO has underperformed in comparison with the industry ...
Bristol-Myers Squibb Withdraws FDA Application for Hepatitis C Treatment  Pharmacy Times
Bristol-Myers Squibb Announces Collaboration to Evaluate Opdivo (nivolumab ...  MarketWatch
Related articles »  
Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for October ...
Bristol-Myers Squibb Company ( BMY ) will begin trading ex-dividend on October 01, 2014. A cash dividend payment of $0.36 per share is scheduled to be paid on November 03, 2014.
Ex-Dividend Reminder: ClubCorp Holdings, Bristol-Myers Squibb and Medtronic  Forbes
Related articles »